Improve Osteoarthritis Care

NCT04670549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1541

Last updated 2023-12-21

No results posted yet for this study

Summary

The purpose of The Improve Osteoarthritis Care study is to improve the quality of osteoarthritis care in Norwegian primary care, by increasing the use of recommended treatment modalities and improving patient access to recommended treatments. The study will use tailored implementation strategies, targeting primary care physicians and physiotherapists to improve knowledge and addressing individual barriers to providing recommended treatments.

Conditions

  • Osteoarthritis, Knee
  • Osteoarthritis, Hip

Interventions

OTHER

Implementation of treatment guidelines

To improve knowledge of OA treatment recommendations among people with hip and knee OA, a lay language summary will be emailed all OA patient participants. A second summary of the treatment recommendations, targeting general practitioners (GPs) will also be emailed the OA patient participants. The patients will be encouraged to print and bring this summary to their GP at the next visit (user-initiated implementation). Barriers and facilitators for providing evidence-based OA care among primary care physiotherapists will be mapped through interviews. Thereafter, a tool-kit of strategies and practical aids intended to help overcome these barriers will be developed and made available for the physiotherapists.

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Nina Østerås · Diakonhjemmet Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-13
Primary Completion
2023-02-09
Completion
2023-07-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670549 on ClinicalTrials.gov